Nitrous oxide

Description

Nitrous Oxide USP is a colorless, non-flammable gas with a slightly sweet odor and taste. Its chemical name is nitrous oxide, and it has a CAS number of 10024-97-2.

Uses and Indications

Nitrous Oxide is indicated for use in medical settings under the supervision of a licensed practitioner who is experienced in its administration. This drug is intended for use in procedures requiring analgesia and sedation, ensuring that the practitioner is equipped to manage its effects and any potential complications.

Limitations of Use: There are no specific teratogenic or nonteratogenic effects associated with Nitrous Oxide as per the available data. However, practitioners should exercise caution and consider the overall clinical context when administering this agent.

Dosage and Administration

Administration of Nitrous Oxide is indicated for use only by or under the supervision of a licensed practitioner experienced in its use and administration, as it may pose hazards or contraindications.

Nitrous Oxide is administered via the respiratory route through inhalation. The active ingredient consists of Nitrous Oxide at a concentration of 99 liters in 100 liters. Healthcare professionals should ensure that the administration is conducted in a controlled environment, adhering to safety protocols and monitoring the patient throughout the procedure.

Contraindications

Administration of Nitrous Oxide is contraindicated in situations where safety precautions have not been fully understood and implemented.

Healthcare professionals should ensure that all safety measures are adhered to prior to handling the gas. Inhalation of the gas should be avoided, as it may pose respiratory risks. Additionally, contact with eyes, skin, or clothing must be prevented to avoid potential irritation or injury.

Warnings and Precautions

Administration of Nitrous Oxide may pose significant risks and is contraindicated in certain situations. It is imperative that this agent is used solely by or under the supervision of a licensed practitioner who possesses expertise in its administration. This practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Hazards and Risks Nitrous Oxide is classified as an oxidizer and may cause or intensify fire. It is stored as a gas under pressure, which presents a risk of explosion if subjected to heat. Users should be aware that exposure to Nitrous Oxide may lead to drowsiness or dizziness, and it has the potential to displace oxygen, resulting in rapid suffocation. Additionally, contact with the gas can cause frostbite.

General Precautions Prior to handling Nitrous Oxide, it is essential that all safety precautions are thoroughly read and understood. The gas should be stored away from clothing and other combustible materials, and care must be taken to keep valves and fittings free from grease and oil. Users should avoid inhaling the gas and prevent contact with eyes, skin, or clothing. Nitrous Oxide should only be used and stored outdoors or in well-ventilated areas. In the event of a fire, efforts should be made to stop the leak if it is safe to do so.

It is crucial to utilize a backflow preventive device in the piping and to ensure that all equipment used is compatible with the materials of construction and rated for cylinder pressure. Equipment must also be cleaned for oxygen service. Valves should be opened slowly, and closed after each use and when empty. Protection from sunlight is necessary when ambient temperatures exceed 52°C (125°F). Users are advised to read and follow the Safety Data Sheet (SDS) prior to use.

Emergency Instructions In case of feeling unwell, it is recommended to contact a poison center or a physician immediately. If Nitrous Oxide comes into contact with the skin, affected areas should be thawed with lukewarm water without rubbing, and immediate medical advice or attention should be sought.

Side Effects

The administration of Nitrous Oxide is associated with several adverse reactions that may vary in seriousness and frequency.

Serious adverse reactions include the potential for rapid suffocation due to oxygen displacement, which poses a significant risk during administration. Additionally, Nitrous Oxide is classified as an oxidizer and may cause or intensify fire hazards, necessitating caution in its use. Frostbite is another serious concern, particularly if the gas is improperly handled or stored.

Common adverse reactions reported include drowsiness and dizziness, which may affect patients during or after administration. These effects highlight the need for careful monitoring of patients receiving Nitrous Oxide.

It is important to note that the administration of Nitrous Oxide may be hazardous or contraindicated in certain situations. Therefore, it should only be used by or under the supervision of a licensed practitioner who possesses the requisite experience in its use. This practitioner should be well-versed in the indications, effects, dosages, methods, and frequency and duration of administration, as well as the associated hazards, contraindications, and necessary precautions.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric use of Nitrous Oxide is not specifically addressed in the available prescribing information. There are no recommended age ranges, dosing differences, safety concerns, or special precautions for pediatric patients mentioned. Healthcare professionals should exercise caution and consider the lack of specific data when contemplating the use of Nitrous Oxide in children.

Geriatric Use

Elderly patients may exhibit increased sensitivity to the effects of Nitrous Oxide. This heightened sensitivity necessitates careful consideration when administering the agent, as it may lead to an enhanced response or adverse effects in this population.

Additionally, it is important to account for the potential for reduced kidney function in geriatric patients. This factor may influence the pharmacokinetics of Nitrous Oxide, warranting dosage adjustments to ensure safety and efficacy.

Healthcare providers should remain vigilant regarding safety concerns specific to elderly patients when administering Nitrous Oxide. Monitoring for adverse reactions and adjusting dosages as needed is essential to mitigate risks associated with this demographic.

Pregnancy

The administration of Nitrous Oxide may pose potential risks during pregnancy, and its use is considered hazardous or contraindicated in this population. While specific safety concerns regarding the use of Nitrous Oxide during pregnancy are not explicitly detailed in the available data, healthcare professionals should exercise caution when considering its administration to pregnant patients. It is advisable to weigh the potential benefits against the risks to fetal outcomes and to explore alternative analgesic options when necessary. Women of childbearing potential should be informed of these considerations when discussing pain management strategies.

Lactation

There are no specific statements regarding the use of this medication in nursing mothers or its effects during lactation. Additionally, there is no available data on the excretion of this medication in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the absence of information when advising lactating mothers about the use of this medication.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function provided in the insert for Nitrous Oxide. Healthcare professionals should exercise caution and consider the lack of data when treating patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of Nitrous Oxide. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for this patient population. It is recommended that healthcare providers exercise caution and consider the overall clinical context when administering Nitrous Oxide to patients with compromised liver function.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate assessment of the patient’s condition is crucial. Recommended actions include:

1. Assessment: Conduct a thorough evaluation of the patient, including vital signs and level of consciousness.

2. Supportive Care: Initiate supportive measures as necessary, which may include airway management, oxygen supplementation, and intravenous fluids.

3. Decontamination: If appropriate and within a reasonable time frame, consider gastrointestinal decontamination methods such as activated charcoal, provided the patient is alert and able to protect their airway.

4. Consultation: Engage with a poison control center or toxicology expert for guidance on specific antidotes or additional management strategies tailored to the substance involved.

It is imperative to monitor the patient closely for any evolving symptoms and to provide symptomatic treatment as required. Documentation of the incident and any interventions performed should be meticulously recorded for future reference and quality assurance.

In summary, while specific overdosage information is not available, healthcare professionals should be prepared to act swiftly and effectively in managing potential overdose situations, ensuring patient safety and optimal outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has revealed several adverse reactions associated with the use of the product. Reports include drowsiness, dizziness, and frostbite. Additionally, there have been instances of rapid suffocation attributed to oxygen displacement. It is noted that the administration of Nitrous Oxide may be hazardous or contraindicated in specific situations.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrous Oxide may pose hazards and is contraindicated in certain situations. It is essential that this substance is used only by or under the supervision of a licensed practitioner who is experienced in its use and familiar with its indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be made aware of the potential dangers associated with Nitrous Oxide, including its ability to cause or intensify fire, as it is classified as an oxidizer. They should understand that the gas is stored under pressure and may explode if subjected to heat. Additionally, patients should be informed that Nitrous Oxide may cause drowsiness or dizziness, and it can displace oxygen, leading to rapid suffocation. Frostbite is also a risk if the gas comes into contact with skin.

Healthcare providers must emphasize the importance of reading and understanding all safety precautions before handling Nitrous Oxide. Patients should be instructed to keep and store the gas away from clothing and other combustible materials, ensuring that valves and fittings remain free from grease and oil. They should avoid breathing the gas and prevent contact with eyes, skin, or clothing. It is crucial to use and store Nitrous Oxide only outdoors or in well-ventilated areas.

In the event of a fire, patients should be advised to stop the leak if it is safe to do so. They should use a backflow preventive device in the piping and ensure that only equipment made of compatible materials and rated for cylinder pressure is utilized. Equipment must be cleaned for oxygen service, and the valve should be opened slowly. Patients should also be reminded to close the valve after each use and when the cylinder is empty, and to protect the gas from sunlight when ambient temperatures exceed 52°C (125°F).

Healthcare providers should encourage patients to read and follow the Safety Data Sheet (SDS) prior to use. In case of inhalation, patients should be instructed to remove themselves to fresh air and remain comfortable for breathing, seeking medical attention if they feel unwell. If Nitrous Oxide comes into contact with skin, patients should thaw the affected area with lukewarm water without rubbing it and seek immediate medical advice or attention.

Storage and Handling

The product is supplied in configurations that ensure safe handling and storage. It is essential to keep and store the product away from clothing and other combustible materials to prevent fire hazards. Valves and fittings must be maintained free from grease and oil to ensure proper functioning and safety.

For optimal use, the product should only be utilized and stored outdoors or in a well-ventilated area. It is crucial to protect the product from direct sunlight when the ambient temperature exceeds 52°C (125°F) to avoid degradation or potential hazards.

When operating the valve, it should be opened slowly to prevent sudden release of contents. Additionally, the valve must be closed securely after each use and when the product is empty to maintain safety and integrity.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide as submitted by Keen Compressed Gas Co. Inc.. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)